Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search

Print

2020 Top Story

- Archives -

Top story: UMass ranks fourth in nation-wide tech licensing survey

Top story: UMass ranks fourth in nation-wide tech licensing survey

The University of Massachusetts ranked fourth among all U.S. institutions and third among universities for generating income from the licensing of faculty-derived discoveries and products in FY 2018, the most recent year for which figures are available.

Top story: Chancellor Collins in Boston Globe: Frequent COVID tests help keep communities safe

Top story: Chancellor Collins in Boston Globe: Frequent COVID tests help keep communities safe

As colleges and universities plan for the return of students for the fall semester amid the COVID-19 pandemic, one important element in keeping everyone safe is frequent testing for the virus, according to Chancellor Michael F. Collins in a July 30 opinion piece published in the Boston Globe.

Top story: From Kolkata to Worcester, GSBS student Kasturi Biswas drawn to science of the brain

Top story: From Kolkata to Worcester, GSBS student Kasturi Biswas drawn to science of the brain

Kasturi Biswas, a PhD candidate in neurobiology, traveled from her native India to Massachusetts to study at UMass Medical School.

Top story: UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests

Top story: UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests

UMass Medical School has been awarded grants totaling more than $100 million to coordinate the nationwide push for fast, accessible COVID-19 testing, playing a major role in the National Institutes of Health’s Rapid Acceleration of Diagnostics, or RADx, program.

Top story: UMass Medical School confers 135 Doctor of Medicine degrees in virtual commencement proceedings

Top story: UMass Medical School confers 135 Doctor of Medicine degrees in virtual commencement proceedings

Virtual graduation proceedings took place months early, enabling members of the School of Medicine Class of 2020 to join the Massachusetts health care workforce immediately to help take on the unprecedented COVID-19 challenge.

Top story: Silencing of an ALS gene safely delivered to patients in UMass Medical School study

Top story: Silencing of an ALS gene safely delivered to patients in UMass Medical School study

UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.

Top story: UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

Top story: UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

UMass Medical School is enrolling healthy volunteers to take part in a Phase II/III clinical trial testing whether a messenger RNA vaccine candidate can prevent infection with the virus that causes COVID-19.

Top story: Nine-story biomedical research and education facility to be built at UMass Medical School

Top story: Nine-story biomedical research and education facility to be built at UMass Medical School

UMass Medical School has received approval from the University of Massachusetts Board of Trustees to build a nine-story biomedical research and education facility on the Worcester campus to support laboratory research growth and the educational enterprise.

Top story: NIH research funding surges at UMass Medical School

Top story: NIH research funding surges at UMass Medical School

National Institutes of Health research funding to UMass Medical School grew by 78 percent for the first quarter of fiscal 2021, which began July 1. Grants and contracts from all funding sources increased by nearly 50 percent.

Inside the new mRNA vaccines for COVID-19

Inside the new mRNA vaccines for COVID-19

The new vaccines by Pfizer/BioNTech and Moderna use messenger RNA to stimulate the immune system to protect against COVID-19. These vaccines are the first of their kind and researchers at UMass Medical School are among the leading RNA biologists in the world.

Showing 1-10 of 188 items
of 19